UBS maintains a 'buy' rating on AB InBev, lowering its target price from 72 to 70 euros, which still suggests a 39% upside for the company behind Stella Artois, Budweiser, and Corona. The firm anticipates AB InBev will achieve organic EBITDA growth of 4-8%, with a projected 7.1% growth for 2025, driven by accelerating sales in the latter half of the year.